Development and Characteiston of Hrebal formulation of Artemisiaannual and morind citrifolial

By:

NITIHIN Kumar Karnati

Material type: Film

FilmSubject(s):

Industrial Pharmacy(338.476 151)

DDC classification:

338.476 151 NIT

Dissertation note: Dissertation 1905-07-04

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Date due	Barcode
ACP-Thesis & Dissertations	Acharya & BM Reddy College of Pharmacy	Acharya & BM Reddy College of Pharmacy	ACP-Indust	338.476 151 NIT (Browse shelf(Opens below))	Available		ACP-T198

Browsing Acharya & BM Reddy College of Pharmacy shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	Next
Previous	338.476 151 Study of polymers as coating agents for possible colon targeted delivery of metronidazole	338.476 151 Formulation development and characterization of gastroretentive microparticles of metformin using ultrasound cavitation	338.476 151 Formulation and evaluation of liposomal hair dyes	338.476 151 NIT Development and Characteiston of Hrebal formulation of Artemisiaannual and morind citrifolial	615 Formulation and Evaluation of Microemulsion Drug Delivery System of Famotidine for Improvement of oral Bioavailability	615 Formulation and Evaluation of Microspheres Containing Sibutramine Hydrochloride for Treatment of Obesity.	615 Formulation and Evaluation of Ethosomes Containing Antifungal Agent	Next

Annual ; Artemisia ; Artemisiaannual ; Characteiston ; Chareuterization ; citrifolial ; Citritolia ; Development ; formulation ; Hrebal ; L ; morind ; Morinda

Dissertation 1905-07-04

There are no comments on this title.

to post a comment.